These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 21076184)

  • 1. Functional stability of endothelial cells on a novel hybrid scaffold for vascular tissue engineering.
    Pankajakshan D; Krishnan V K; Krishnan LK
    Biofabrication; 2010 Dec; 2(4):041001. PubMed ID: 21076184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular tissue generation in response to signaling molecules integrated with a novel poly(epsilon-caprolactone)-fibrin hybrid scaffold.
    Pankajakshan D; Krishnan V K; Krishnan LK
    J Tissue Eng Regen Med; 2007; 1(5):389-97. PubMed ID: 18038433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular tissue construction on poly(ε-caprolactone) scaffolds by dynamic endothelial cell seeding: effect of pore size.
    Mathews A; Colombus S; Krishnan VK; Krishnan LK
    J Tissue Eng Regen Med; 2012 Jun; 6(6):451-61. PubMed ID: 21800434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth factors upregulate deposition and remodeling of ECM by endothelial cells cultured for tissue-engineering applications.
    Divya P; Sreerekha PR; Krishnan LK
    Biomol Eng; 2007 Dec; 24(6):593-602. PubMed ID: 17869171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of passage number and matrix characteristics on differentiation of endothelial cells cultured for tissue engineering.
    Prasad Chennazhy K; Krishnan LK
    Biomaterials; 2005 Oct; 26(28):5658-67. PubMed ID: 15878371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of tissue-engineered heart valves by using decellularized scaffolds and endothelial progenitor cells.
    Fang NT; Xie SZ; Wang SM; Gao HY; Wu CG; Pan LF
    Chin Med J (Engl); 2007 Apr; 120(8):696-702. PubMed ID: 17517187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of endothelial cell phenotype by biomimetic matrix coated on biomaterials for cardiovascular tissue engineering.
    Prasad CK; Krishnan LK
    Acta Biomater; 2008 Jan; 4(1):182-91. PubMed ID: 17643359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of fibrin matrix composition to enhance endothelial cell growth and extracellular matrix deposition for in vitro tissue engineering.
    Pankajakshan D; Krishnan LK
    Artif Organs; 2009 Jan; 33(1):16-25. PubMed ID: 19178437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shear-stress preconditioning and tissue-engineering-based paradigms for generating arterial substitutes.
    Baguneid M; Murray D; Salacinski HJ; Fuller B; Hamilton G; Walker M; Seifalian AM
    Biotechnol Appl Biochem; 2004 Apr; 39(Pt 2):151-7. PubMed ID: 15032735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human endothelial cell growth on mussel-inspired nanofiber scaffold for vascular tissue engineering.
    Ku SH; Park CB
    Biomaterials; 2010 Dec; 31(36):9431-7. PubMed ID: 20880578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human endothelial cell growth and phenotypic expression on three dimensional poly(lactide-co-glycolide) sintered microsphere scaffolds for bone tissue engineering.
    Jabbarzadeh E; Jiang T; Deng M; Nair LS; Khan YM; Laurencin CT
    Biotechnol Bioeng; 2007 Dec; 98(5):1094-102. PubMed ID: 17497742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycosaminoglycans restrained in a fibrin matrix improve ECM remodelling by endothelial cells grown for vascular tissue engineering.
    Divya P; Krishnan LK
    J Tissue Eng Regen Med; 2009 Jul; 3(5):377-88. PubMed ID: 19452443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chondrogenesis using mesenchymal stem cells and PCL scaffolds.
    Kim HJ; Lee JH; Im GI
    J Biomed Mater Res A; 2010 Feb; 92(2):659-66. PubMed ID: 19235210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro fabrication of a tissue engineered human cardiovascular patch for future use in cardiovascular surgery.
    Yang C; Sodian R; Fu P; Lüders C; Lemke T; Du J; Hübler M; Weng Y; Meyer R; Hetzer R
    Ann Thorac Surg; 2006 Jan; 81(1):57-63. PubMed ID: 16368335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bio-mimetic composite matrix that promotes endothelial cell growth for modification of biomaterial surface.
    Prasad CK; Muraleedharan CV; Krishnan LK
    J Biomed Mater Res A; 2007 Mar; 80(3):644-54. PubMed ID: 17051537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gradient nanofibrous chitosan/poly ɛ-caprolactone scaffolds as extracellular microenvironments for vascular tissue engineering.
    Du F; Wang H; Zhao W; Li D; Kong D; Yang J; Zhang Y
    Biomaterials; 2012 Jan; 33(3):762-70. PubMed ID: 22056285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary experience with tissue engineering of a venous vascular patch by using bone marrow-derived cells and a hybrid biodegradable polymer scaffold.
    Cho SW; Jeon O; Lim JE; Gwak SJ; Kim SS; Choi CY; Kim DI; Kim BS
    J Vasc Surg; 2006 Dec; 44(6):1329-40. PubMed ID: 17145438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward engineering a human neoendothelium with circulating progenitor cells.
    Allen JB; Khan S; Lapidos KA; Ameer GA
    Stem Cells; 2010 Feb; 28(2):318-28. PubMed ID: 20013827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The application of type II collagen and chondroitin sulfate grafted PCL porous scaffold in cartilage tissue engineering.
    Chang KY; Hung LH; Chu IM; Ko CS; Lee YD
    J Biomed Mater Res A; 2010 Feb; 92(2):712-23. PubMed ID: 19274722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial cells derived from circulating progenitors as an effective source to functional endothelialization of NaOH-treated poly(epsilon-caprolactone) films.
    Serrano MC; Pagani R; Ameer GA; Vallet-Regí M; Portolés MT
    J Biomed Mater Res A; 2008 Dec; 87(4):964-71. PubMed ID: 18257077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.